1. Evaluation of a multi-atlas CT synthesis approach for MRI-only radiotherapy treatment planning. (March 2017) Authors: Guerreiro, F.; Burgos, N.; Dunlop, A.; Wong, K.; Petkar, I.; Nutting, C.; Harrington, K.; Bhide, S.; Newbold, K.; Dearnaley, D.; deSouza, N.M.; Morgan, V.A.; McClelland, J.; Nill, S.; Cardoso, M.J.; Ourselin, S.; Oelfke, U.; Knopf, A.C. Journal: Physica medica Issue: Volume 35(2017) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improvement in Dysphagia Outcomes Following Clinical Target Volume Reduction in the De-ESCALaTE Study. Issue 12 (December 2021) Authors: Vreugdenhil, M.; Fong, C.; Iqbal, G.; Roques, T.; Evans, M.; Palaniappan, N.; Yang, H.; O'Toole, L.; Sanghera, P.; Nutting, C.; Foran, B.; Sen, M.; Al Booz, H.; Fulton-Lieuw, T.; Dalby, M.; Dunn, J.; Hartley, A.; Mehanna, H. Journal: Clinical oncology Issue: Volume 33:Issue 12(2021) Page Start: 795 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The impact of the number of atlases on the performance of automatic multi-atlas contouring. (November 2015) Authors: Larrue, A.; Gujral, D.; Nutting, C.; Gooding, M. Journal: Physica medica Issue: Volume 31(2015)Supplement 2 Page Start: e30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 11LBA Differences in the quality of life (QoL) and functional outcomes of treatment between HPV associated (HPV+) and HPV- patients receiving primary chemoradiotherapy in PET-NECK - a multi-centre randomized phase III controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNC) treated with primary radical chemoradiotherapy (CRT). (September 2015) Authors: Mehanna, H.; Wong, W.L.; McConkey, C.C.; Rahman, J.K.; Robinson, M.; Hartley, A.; Nutting, C.; Powell, N.; Al-Booz, H.; Robinson, M.; Junor, E.; Hulme, C.; Smith, A.F.; Hall, P.; Dunn, J.A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S715 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Rapid advances in auto-segmentation of organs at risk and target volumes in head and neck cancer. (June 2019) Authors: Kosmin, M.; Ledsam, J.; Romera-Paredes, B.; Mendes, R.; Moinuddin, S.; de Souza, D.; Gunn, L.; Kelly, C.; Hughes, C.O.; Karthikesalingam, A.; Nutting, C.; Sharma, R.A. Journal: Radiotherapy and oncology Issue: Volume 135(2019) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-0858: Development of dysphagia optimised IMRT for head and neck cancer treatment in the DARS trial. (April 2016) Authors: Tyler, J.; Bernstein, D.; Rooney, K.; Nutting, C. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Improvement of delineation quality of organs at risk in head and neck using the consensus guidelines. (April 2016) Authors: Steenbakkers, R.; Brouwer, C.; Bourhis, J.; Budach, W.; Grau, C.; Grégoire, V.; Van Herk, M.; Lee, A.; Maingon, P.; Nutting, C.; O'Sullivan, B.; Porceddu, S.; Rosenthal, D.; Sijtsema, N.; Langendijk, J. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S137 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SP-0001 Developing a national infrastructure for proton beam therapy trials. (May 2022) Authors: Nutting, C. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC-0573: Improvement in late dysphagia following clinical target volume reduction in the De-ESCALaTE study. (November 2020) Authors: Fong, C.T.K.; Mistry, P.; Roques, T.; Evans, M.; Yang, H.Q.; O'Toole, L.; Sanghera, P.; Nutting, C.; Foran, B.; Sen, M.; Al Booz, H.; Fulton-Lieuw, T.; Dalby, M.; Dunn, J.; Hartley, A.; Mehanna, H. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 76: Patterns of extra-cranial disease progression in epidermal growth factor receptor (EGFR) mutant metastatic non-small cell lung cancer (NSCLC) patients on a tyrosine kinase inhibitor (TKI). (January 2015) Authors: Aitken, K.; Popat, S.; Nutting, C.; McDonald, F. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗